(+)-Matrine

CAS No. 519-02-8

(+)-Matrine( NSC 146051 | NSC 318810 )

Catalog No. M14816 CAS No. 519-02-8

Matrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 32 Get Quote
50MG 48 Get Quote
100MG 67 Get Quote
500MG 237 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (+)-Matrine
  • Note
    Research use only, not for human use.
  • Brief Description
    Matrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.
  • Description
    Matrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.
  • In Vitro
    Cell Viability Assay Cell Line:A549, SMMC-7721 cells Concentration:0-500 μg/mL for A549 cells, 0-1.5 mg/mL for SMMC-7721 cellsIncubation Time:24-72 h Result:Inhibited the growth of A549 and SMMC-7721 cells.Western Blot AnalysisCell Line:A549, SMMC-7721 cells Concentration:100-250 μg/mL for A549 cells, 0.5-1 mg/mL for SMMC-7721 cellsIncubation Time:24 h Result:Down-regulated the expression of anti-apoptotic protein (Bcl-2) and up-regulated the level of pro-apoptotic protein (bax).ImmunofluorescenceCell Line:HK2 cells Concentration:10 μM Incubation Time:48 h Result:Increased SIRT3 expression reduced under cisplatin stimuli.
  • In Vivo
    Animal Model:Xenograft male C57BL/6mice model (LLC cells)Dosage:40 and 80 mg/kg for 16 consecutive days Administration:Intragastric administration Result:Inhibited tumors growth.Decreased the ratio of CD206+/F4/80+, promoted the expression of CD4+ and CD8+ T cells, and inhibited the expression of Th2 in tumor and spleen tissues. Animal Model:Cisplatin-induced acute kidney injury (AKI) mice model Dosage:5 mg/kg daily for 4 days Administration:Intraperitoneal injections Result:Attenuated tubular injury observed in AKI mice, including renal tubular necrosis,formation of tubular casts, cytoplasmic vacuoles and renal infiltrationof inflammatory cells in mice.Decreased serum levels of TNF-a and IL-6 and the phosphorylation of NF-κB, activated SIRT3/OPA1 axis and improved mitochondrial function.
  • Synonyms
    NSC 146051 | NSC 318810
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    κ-opioid receptor
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    519-02-8
  • Formula Weight
    248.37
  • Molecular Formula
    C15H24N2O
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 49 mg/mL (197.29 mM); Water: 11 mg/mL warmed (44.29 mM); DMSO: 49 mg/mL (197.29 mM)
  • SMILES
    O=C1CCC[C@@H]2[C@H]3CCCN4CCC[C@H]([C@@H]34)CN12
  • Chemical Name
    (41S,7aS,13aR,13bR)-dodecahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ren H, et al. Acta Biochim Biophys Sin (Shanghai). 2014 Dec;46(12):1049-55.
molnova catalog
related products
  • SCH 221510

    SCH 221510 is an orally available, selective and potent NOP agonist with an EC50 of 12 nM and a Ki of 0.3 nM.SCH 221510 has anxiolytic activity and can be used to study neurological disorders.

  • CTAP

    Potent and selective μ opioid receptor antagonist (IC50 = 3.5 nM). Displays > 1200-fold selectivity over δ opioid and somatostatin receptors. Brain penetrant and active in vivo.

  • Ac-RYYRWK-NH2

    Potent, selective partial agonist peptide for the NOP receptor (Ki = 0.71 nM). Selective over μ, δ and κ opioid receptors (IC50 > 4000 nM). Increases food intake in vivo.